INS and gestational diabetes: Despite studies that identified independent risk factors for GDM treatment (mostly insulin versus MNT alone) [21–27], studies focusing on the development of risk prediction models are limited, which further suffered from methodological limitations and collectively limited the generalizability of developed models.